| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |